Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Organotchi: an open-source tool for the automated segmentation, morphological characterization, and longitudinal tracking of organoids

Created on 07 Nov 2026

Authors

Branco, L., Lautenschlager, T., Andreeva, D., Yentur, Z., Castagnetti, F., Kagermeier, T., Potthof, I., Collignon, P., Potter Stephens, K., Matilainen, J., Mikut, R., Mayer, S.

Abstract

Neural organoids are three-dimensional stem cell-derived models widely used to study brain development and model disease. Brightfield imaging offers a non-invasive readout of their growth and morphology, and recent advances have made automated organoid segmentation from such images increasingly attainable. Yet existing tools largely leave morphological characterization, quality assessment, and comparisons between conditions to manual or ad hoc analysis. Here we present Organotchi, an open-source tool that integrates automated segmentation with longitudinal morphological analysis of neural organoids. Organotchi quantifies ten morphological features, including area, perimeter, and eccentricity, and tracks cystic structures over time, reports variability within and between batches, and flags outlier organoids and segmentation failures, supporting objective organoid characterization and enhancing downstream analysis. As a proof of concept, we apply Organotchi to disease modelling, pharmacological perturbation, and protocol optimization in neural organoids. One use case assesses drug response in breast cancer spheroids, demonstrating its use beyond its development domain.

Preprint server: bioRxiv
The authors list and abstract were imported from bioRxiv on 07 Nov 2026.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this preprint? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 11
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement